human lung
3D Printing Financials: 3D Systems Misses Revenues by 9.32%, Targets 2027 for Clinical Human Lung Trials
In the latest financial unveiling, 3D Systems (NYSE: DDD) shared its fiscal report for the last quarter of 2023 and the entire year, shedding light on its struggles and strategic…
Daring AM: is Australia Leading the Bioprinting Revolution?
Is Australia the land of bioprinting wonders? As news of the country’s efforts in bioprinting continues to emerge, it becomes clear that researchers are pushing the boundaries of medical science….
